Cofactor-directed reversible denaturation pathways: the cofactor-stabilized Escherichia coli aspartate aminotransferase homodimer unfolds through a pathway that differs from that of the apoenzyme.

Cofactor-directed reversible denaturation pathways: the cofactor-stabilized Escherichia coli aspartate aminotransferase homodimer unfolds through a pathway that differs from that of the apoenzyme. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Cofactor-directed reversible denaturation pathways: the cofactor-stabilized Escherichia coli aspartate aminotransferase homodimer unfolds through a pathway that differs from that of the apoenzyme. Abstract Text:

Edgar Deu,Jack F Kirsch,

While the urea-mediated unfolding pathway of the Escherichia coli aspartate aminotransferase (eAATase) homodimer proceeds through a reversible three-state process with a partially folded dimeric intermediate, D D* 2U (E. Deu and J. F. Kirsch, accompanying paper), that of a cofactor-stabilized form differs. Pyridoxal phosphate, which binds at the intersubunit active sites, stabilizes the native form by 6 kcal mol-1 and dissociates during the D <==> D* transition. Reductive trapping of the cofactor to a nondissociable derivative (PPL-eAATase) precludes the formation of D*. A novel monomeric intermediate (M'-PPL) with 70% of the native secondary structure (circular dichroism) was identified in the unfolding pathway of PPL-eAATase: D-PPL2 <==> 2M'-PPL <==> 2U-PPL. The combined results define two structural regions with distinct stabilities: the active site region (ASR) and the generally more stable, dimerization region (DMR). The DMR includes the key intersubunit contacts. It is responsible for the multimeric nature of D*, and its disorder leads to dimer dissociation. Selective strengthening of the ASR-cofactor interactions by cofactor trapping reverses the relative stabilities of the two regions (from DMR > ASR in the apoenzyme to ASR > DMR in PPL-eAATase) and results in a reordering of the eAATase denaturation pathway.

Cofactor-directed reversible denaturation pathways: the cofactor-stabilized Escherichia coli aspartate aminotransferase homodimer unfolds through a pathway that differs from that of the apoenzyme. Publishing Authors By Initials

E Deu,JF Kirsch,

For similar organic chemicals: urea research abstracts see: organic chemicals: urea research

PUBMED ID PMID:

MEDLINE DATE:

Cofactor-directed reversible denaturation pathways: the cofactor-stabilized Escherichia coli aspartate aminotransferase homodimer unfolds through a pathway that differs from that of the apoenzyme. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: Biochemistry

VOLUME: 46

Page Numbers: 5819-29

Journal Abbreviation: Biochemistry

ISSN: 0006-2960

DAY: 19

MONTH: 04

YEAR: 2007

Cofactor-directed reversible denaturation pathways: the cofactor-stabilized Escherichia coli aspartate aminotransferase homodimer unfolds through a pathway that differs from that of the apoenzyme. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 370623

Cofactor-directed reversible denaturation pathways: the cofactor-stabilized Escherichia coli aspartate aminotransferase homodimer unfolds through a pathway that differs from that of the apoenzyme. Keywords Mesh Terms:

KEYWORDS: Urea

MESH TERMS: pharmacology

Chemical & Substance for Abstract: Cofactor-directed reversible denaturation pathways: the cofactor-stabilized Escherichia coli aspartate aminotransferase homodimer unfolds through a pathway that differs from that of the apoenzyme. Information

Substance Name: Aspartate Aminotransferases

Registry Number: EC 2.6.1.1

Grant and Affiliation Information for Cofactor-directed reversible denaturation pathways: the cofactor-stabilized Escherichia coli aspartate aminotransferase homodimer unfolds through a pathway that differs from that of the apoenzyme.

AFFILIATION: Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, California 94720-3206, USA.

Country: United States

AGENCY: United States NIGMS

GRANT: GM 35393

ACRONYM: GM

MEDLINETA: Biochemistry

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Cofactor-directed reversible denaturation pathways: the cofactor-stabilized Escherichia coli aspartate aminotransferase homodimer unfolds through a pathway that differs from that of the apoenzyme Related Publications

• 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense?
• Annexin V/beta5 integrin interactions regulate apoptosis of growth plate chondrocytes.
• Cofactor-directed reversible denaturation pathways: the cofactor-stabilized Escherichia coli aspartate aminotransferase homodimer unfolds through a pathway that differs from that of the apoenzyme.
• Development of a neuroprosthesis for restoring arm and hand function via functional electrical stimulation following high cervical spinal cord injury.
• Duty hours restriction and their effect on resident education and academic departments: the American perspective.
• EMG-based Control for a C5/C6 Spinal Cord Injury Upper Extremity Neuroprosthesis.
• Effects of spinal cord injury on lower-limb passive joint moments revealed through a nonlinear viscoelastic model.
• Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain.
• Hypnosis for nausea and vomiting in cancer chemotherapy: a systematic review of the research evidence.
• Identification of functional paralog shift mutations: conversion of Escherichia coli malate dehydrogenase to a lactate dehydrogenase.
• Immunophenotypes in the circulation of patients with mild cognitive impairment.
• Increased production of inflammatory cytokines in mild cognitive impairment.
• Influence of vigilance and learning on prefrontal activation in schizophrenia.
• Iron, copper, and iron regulatory protein 2 in Alzheimer's disease and related dementias.
• Iterative approach to polyketide-type structures: stereoselective synthesis of 1,3-polyols utilizing the catalytic asymmetric Overman esterification.
• Keeping Pace With GI Technology: Knowing When to Get Out.
• Mechanisms of seizure propagation in a cortical model.
• N-nitroso-melatonin releases nitric oxide in the presence of serotonin and its derivatives.
• Oral cavity cancer.
• Percutaneous multilevel decompressive laminectomy, foraminotomy, and instrumented fusion for cervical spondylotic radiculopathy and myelopathy: assessment of feasibility and surgical technique.
• Perioperative care of patients with neuromuscular disease and dysfunction.
• Preliminary demonstration of an allelic association of the IREB2 gene with Alzheimer's disease.
• Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counseling.
• Recombinant expression of twelve evolutionarily diverse subfamily Ialpha aminotransferases.
• Regional dissection and determination of loosely bound and non-heme iron in the developing mouse brain.
• Sigma receptor agonists provide neuroprotection in vitro by preserving bcl-2.
• Structure and function analysis of the CMS/CIN85 protein family identifies actin-bundling properties and heterotypic-complex formation.
• Sutureless circumcision using 2-octyl cyanoacrylate (Dermabond): appraisal after 18-month experience.
• The unfolding pathway for Apo Escherichia coli aspartate aminotransferase is dependent on the choice of denaturant.
• [Not Available.]